Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Finance

4Q21 Wrap: the bleeding continues

Biopharmas continued to slump in 4Q21 across all market cap tiers

January 15, 2022 1:24 AM UTC

Biopharma stocks continued to spiral downwards across all market cap tiers in 4Q21. Megacaps showed the least amount of bleeding with a median loss in market cap of 5%, while microcaps lost a median of 19%.

French diagnostics player bioMerieux S.A. (Euronext:BIM) led gainers in the megacap group, defined as companies that started the quarter with valuations of $10 billion or more. The company had a 25% jump in its market cap following news that its tests can detect the Omicron variant of SARS-CoV-2...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article